口服输送疫苗的市场规模，份额，增长和行业分析，按类型（轮状病毒疫苗，霍乱疫苗，口服脊髓灰质炎疫苗），按应用（公共和私人）以及到2031年的区域预测。
地区： 全球的 | 格式： PDF | 报告编号： PMI2175 | SKU 编号： 26440186 | 页数： 132 | 发布日期 : April, 2024 | 基准年份： 2023 | 历史数据： 2019 - 2022
全球口服输送疫苗市场研究报告2024（状态和前景）
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oral Delivery Vaccines
1.2 Key Market Segments
1.2.1 Oral Delivery Vaccines Segment by Type
1.2.2 Oral Delivery Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown和数据三角剖分
1.3.4基础年
1.3.5报告假设和注意事项
2口服疫苗疫苗市场市场概述
2.1全球市场概述
2.1.1全球口服疫苗市场大小（M USD）和预测（2019-2030-2.1.1.2 Global saless
全球销售估算） （2019-2030）
2.2市场部门执行摘要
2.3全球市场规模按地区按地区
3口接种疫苗市场竞争竞争竞争竞争格局
3.1全球口服疫苗制造商的销售（2019-2024）（2019-2024）
3.2 3.2全球口服交付疫苗市场份额由制造商的股票（2019-20-20-20-2024）<3.3或BR> BR> 3.3或BR> BR> BR> BR> BR> 3.3或BR> BR> BR> BR> BR> BR> BR> BR> BR> BR> BR> BR> BR> BR> BR> BR> BR> BR）
BR> BR> BR> BR> BR） Tier 2, and Tier 3)
3.4 Global Oral Delivery Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oral Delivery Vaccines Sales Sites, Area Served, Product Type
3.6 Oral Delivery Vaccines Market Competitive Situation and Trends
3.6.1 Oral Delivery Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oral Delivery Vaccines Players Market Share by收入
3.6.3并购，扩展
4口接种疫苗产业链分析
4.1口接种疫苗产业链分析
4.2关键原材料的市场概述
4.3中流市场分析
中流市场分析
4.4下游客户分析
下游客户分析
5.br> 5 5.1的开发率5.1 5.1驱动因素<1 5.1 keetions <1 5.1 keetions <1 5. 1市场挑战
5.4市场限制
5.5行业新闻
5.5.1新产品开发
5.5.2并购
5.5.3 5.5.3 5.5.3 5.5.4协作/供应合同
5.6 5.6行业策略
6口服交付疫苗划分全球范围
6.1评估Market Intivation
6.1评估METALIX
6.1评估Materix
疫苗按类型（2019-2024）按类型按销售市场份额
6.3全球口头输送疫苗按类型（2019-2024）按类型（2019-2024）按类型（2019-2024）按类型（2019-2024）按应用程序进行的全球口服交付疫苗价格
7口接种疫苗按应用程序进行市场分割，按应用程序进行市场分割，
7.1的应用程序
7.1 epplact opplact offerase Market Offerations Market Offerage Market Offercation
7.1 epplact epplace Matrix
2.2 (2019-2024)
7.3 Global Oral Delivery Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Oral Delivery Vaccines Sales Growth Rate by Application (2019-2024)
8 Oral Delivery Vaccines Market Segmentation by Region
8.1 Global Oral Delivery Vaccines Sales by Region
8.1.1 Global Oral Delivery Vaccines Sales by Region
8.1.2 Global Oral Delivery Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Oral Delivery Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oral Delivery Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5意大利
8.3.6俄罗斯
8.4亚太地区
8.4.1亚太口服疫苗按地区进行疫苗销售
8.4.2中国
8.4.3日本
日本
8.4.4韩国8.4.4印度
印度8.4.4 8.4.4 8.4.6 South East Asia
South Asia
South Univers
South America
South Amerry sales
sales
sales
sales <5.5.2.2 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oral Delivery Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Oral Delivery Vaccines Basic Information
9.1.2 Merck Oral Delivery Vaccines Product Overview
9.1.3 Merck Oral Delivery Vaccines Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Oral Delivery Vaccines SWOT Analysis
9.1.6 Merck Recent Developments
9.2 GSK
9.2.1 GSK Oral Delivery Vaccines Basic Information
9.2.2 GSK Oral Delivery Vaccines Product Overview
9.2.3 GSK Oral Delivery Vaccines Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Oral Delivery Vaccines SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi
9.3.1 Sanofi Oral Delivery Vaccines Basic Information
9.3.2 Sanofi Oral Delivery Vaccines Product Overview
9.3.3 Sanofi Oral Delivery Vaccines Product Market Performance
9.3.4 Sanofi Oral Delivery Vaccines SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Lanzhou Institute
9.4.1 Lanzhou Institute Oral Delivery Vaccines Basic信息
9.4.2 Lanzhou Institute口服疫苗产品概述
9.4.3 Lanzhou研究所口服疫苗产品市场绩效
9.4.4 Lanzhou Institute Business概述
9.4.44.5 Lanzhh lanzhou最近的发展近期发展
9.5 Serum Institute Instute factute
9.5.1.5.1.5.1.5.15.15.5.9.5.9.5.15.15.5.。 Institute Oral Delivery Vaccines Product Overview
9.5.3 Serum Institute Oral Delivery Vaccines Product Market Performance
9.5.4 Serum Institute Business Overview
9.5.5 Serum Institute Recent Developments
9.6 Valneva
9.6.1 Valneva Oral Delivery Vaccines Basic Information
9.6.2 Valneva Oral Delivery Vaccines Product Overview
9.6.3 Valneva Oral Delivery Vaccines Product Market Performance
9.6.4 Valneva Business Overview
9.6.5 Valneva Recent Developments
9.7 Shanghai United Cell
9.7.1 Shanghai United Cell Oral Delivery Vaccines Basic Information
9.7.2 Shanghai United Cell Oral Delivery Vaccines Product Overview
9.7.3 Shanghai United Cell Oral Delivery Vaccines Product Market Performance
9.7.4 Shanghai United Cell Business Overview
9.7.5 Shanghai United Cell Recent Developments
9.8 Bibcol
9.8.1 Bibcol Oral Delivery Vaccines Basic Information
9.8.2 Bibcol Oral Delivery Vaccines Product Overview
9.8.3 Bibcol Oral Delivery Vaccines Product Market Performance
9.8.4 Bibcol Business Overview
9.8.5 Bibcol Recent Developments
9.9 PaxVax
9.9.1 PaxVax Oral Delivery Vaccines Basic Information
9.9.2 PaxVax Oral Delivery Vaccines Product Overview
9.9.3 PaxVax Oral Delivery Vaccines Product Market Performance
9.9.4 PaxVax Business Overview
9.9.5 PaxVax Recent Developments
9.10 Vabiotech
9.10.1 Vabiotech Oral Delivery Vaccines Basic Information
9.10.2 Vabiotech Oral Delivery Vaccines Product Overview
9.10.3 Vabiotech Oral Delivery Vaccines Product Market Performance
9.10.4 Vabiotech业务概述
9.10.5 Vabiotech最近的发展
9.11 Tiantan Biological
9.11.1 Tiantan Biological Oral递送疫苗基本信息基本信息
9.11.2 Tiantan Biological Oral Oral Oral Oral Oral Oral Proface疫苗产品概述概述概述
9.11.11.3 Tiantan Biologilan Biologal Oralodic Orality valiant vallodic vallolical vallolical vallican prossment ysermart ysermart ybr ybr
10.11。 Overview
9.11.5 Tiantan Biological Recent Developments
9.12 EuBiologics
9.12.1 EuBiologics Oral Delivery Vaccines Basic Information
9.12.2 EuBiologics Oral Delivery Vaccines Product Overview
9.12.3 EuBiologics Oral Delivery Vaccines Product Market Performance
9.12.4 EuBiologics Business概述
9.12.5生态学最新的发展
9.13 Panacea Biotec Ltd
9.13.1 Panacea Biotec Ltd口服输送疫苗基本信息基本信息
9.13.2 Panacea Biotec Ltd biotec ltd口服输送疫苗产品覆盖疫苗范围panice offerview
panacec ltanacec ltdd pandd ltdd ltdd ltdd ltd ltdd ltdd ltd ltd ltdd ltdd ltdd ltd ltdd ltdd ltdd ltd ltdd ltd ltdd ltdd ltd ltd ltd ltd ltd ltd ltd Performance
9.13.4 Panacea Biotec Ltd Business Overview
9.13.5 Panacea Biotec Ltd Recent Developments
9.14 Bio-Med
9.14.1 Bio-Med Oral Delivery Vaccines Basic Information
9.14.2 Bio-Med Oral Delivery Vaccines Product Overview
9.14.3 Bio-Med Oral Delivery Vaccines Product Market性能
9.14.4生物医生业务概述
9.14.5 Bio-Med最近的进展
9.15 Halfkin Halfkin Bio-Pharmaceuticals
9.15.1 Halfkin Bio-Pharmaceuticals口服口服疫苗的口服疫苗基本信息基本信息基本信息
9.15.2 Halfkin bio-pharmace offelix viccines offelix viccine viccine viccine profact
viccine viccine
3.3生物制药的口服疫苗产品市场绩效
9.15.4半生物生物 - 药品业务概述
9.15.5 Halfkin Bio-Pharmaceuticals最近的发展近期发展
10口服交付疫苗
by ryage by face by By By By By By By By By Brove
全球口腔交付疫苗
全球口腔交付疫苗
全球口服疫苗
全球销售疫苗
10.2全球范围
10.2 10.2 Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oral Delivery Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Oral Delivery Vaccines Market Size Forecast by Region
10.2.4 South America Oral Delivery Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oral Delivery Vaccines by Country
11 Forecast Market by Type and by应用程序（2025-2030）
11.1全球口服疫苗疫苗市场按类型（2025-2030）的预测预测（2025-2030）
11.1.1 11.1.1按类型（2025-2030）类型（2025-2030）
11.1.1.1.1.2全球预测口服疫苗的销售
11.1.2全球口服交付疫苗的市场大小，以预期为（2025-2030）的全球送货疫苗的销售量。 by Type (2025-2030)
11.2 Global Oral Delivery Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Oral Delivery Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Oral Delivery Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings